You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Kallikrein 4 (KLK4) Antibodies

Full name:
anti-Kallikrein-Related Peptidase 4 Antibodies (KLK4)
On are 57 Kallikrein-Related Peptidase 4 (KLK4) Antibodies from 23 different suppliers available. Additionally we are shipping Kallikrein 4 Proteins (25) and Kallikrein 4 Kits (6) and many more products for this protein. A total of 92 Kallikrein 4 products are currently listed.
AI2A1, ARM1, EMSP, Emsp1, ESMP1, kallikrein, KLK-L1, PRSS17, PSTS
list all antibodies Gene Name GeneID UniProt
KLK4 56640  
KLK4 9622 Q9Y5K2
KLK4 408210  

Show all species

Show all synonyms

Most Popular Reactivities for anti-Kallikrein 4 (KLK4) Antibodies

Select your species and application

anti-Mouse (Murine) Kallikrein 4 Antibodies:

anti-Human Kallikrein 4 Antibodies:

anti-Rat (Rattus) Kallikrein 4 Antibodies:

All available anti-Kallikrein 4 Antibodies

Go to our pre-filtered search.

Top referenced anti-Kallikrein 4 Antibodies

  1. Human Polyclonal Kallikrein 4 Primary Antibody for WB - ABIN390304 : Xi, Klokk, Korkmaz, Kurys, Elbi, Risberg, Danielsen, Loda, Saatcioglu: Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. in Cancer research 2004 (PubMed)
    Show all 4 references for ABIN390304

More Antibodies against Kallikrein 4 Interaction Partners

Mouse (Murine) Kallikrein-Related Peptidase 4 (KLK4) interaction partners

  1. normal enamel maturation is regulated by TGF-ss signaling through the expression of KLK4

  2. The breakage of enamel near the dentino-enamel junction in Klk4-null mice is not due to a failure of odontoblasts to express Klk4, but it relates to a progressive hypomineralization of enamel with depth.

  3. Effect of kallikrein 4 loss on enamel mineralization: comparison with mice lacking matrix metalloproteinase 20 (show MMP20 Antibodies).

  4. expression of KLK4 correlates with the stage-associated changes in the digestion of enamel proteins

  5. Mice lacking expression of the AmelX (show AMELX Antibodies), Enam (show ENAM Antibodies) and Mmp20 (show MMP20 Antibodies) genes have been generated.

  6. Dipeptidyl peptidase I (show CTSC Antibodies) activates pro-KLK4 to cleave a fluorogenic peptide containing a KLK4 cleavage site in mice incisor enamel organs during amelogenesis. site.

  7. Klk4 is essential for the removal of enamel proteins and the proper maturation of enamel crystals in mice

Human Kallikrein-Related Peptidase 4 (KLK4) interaction partners

  1. Novel homozygous mutations in the KLK4 (c.620_621delCT, p.Ser207Trpfs*38) were identified in amelogenesis imperfecta consanguinity. Mutant KLK4 was degraded intracellularly and became inactive.

  2. this study provides supportive evidence in favor of a prognostic value for KLK4 in OSCC and suggests that KLK4 could serve as a potential therapeutic target in patients with oral cancer.

  3. Human ephrin-B2 (show EFNB2 Antibodies) is poorly cleaved by KLK4 while the homologous mouse is not.

  4. miR (show MLXIP Antibodies)-378 was predicted to target both KLK2 (show KLK2 Antibodies) and KLK4 and downregulated levels detected in prostate cancer patients.

  5. The differential regulation of alternative transcripts (using KLK2 (show KLK2 Antibodies), KLK3 (show KLKB1 Antibodies) and KLK4 as models) by androgens and anti-androgens as an indicator of prostate cancers, was investigated.

  6. KLK4 mRNA positivity could be regarded as a novel independent indicator of favorable prognosis for the disease-free survival of laryngeal squamous cell carcinoma patients.

  7. The variant rs1722561 of Kallikreins might reduce the risk of sporadic intracranial aneurysms among individuals of Chinese Han ethnicity.

  8. These results demonstrate that the activities of AR and mTOR (show FRAP1 Antibodies) pathways are maintained by KLK4, which may thus be a viable target for therapy

  9. Survival analysis demonstrated that KLK4 mRNA expression constitutes an unfavorable prognostic biomarker in colorectal adenocarcinoma, predicting poor disease-free survival (DFS (show FST Antibodies)), independently of the nodal status and tumor size.

  10. amelogenesis imperfecta-causing mutations were identified in three of the probands: 1) a novel single-nucleotide deletion in both KLK4 alleles (g.6930delG; c.245delG; p.Gly82Alafs*87) that shifted the reading frame.

Kallikrein 4 (KLK4) Antigen Profile

Antigen Summary

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. In some tissues its expression is hormonally regulated. The expression pattern of a similar mouse protein in murine developing teeth supports a role for the protein in the degradation of enamel proteins. Alternate splice variants for this gene have been described, but their biological validity has not been determined.

Alternative names and synonyms associated with Kallikrein 4 (KLK4)

  • kallikrein related-peptidase 4 (prostase, enamel matrix, prostate) (Klk4) antibody
  • kallikrein-related peptidase 4 (KLK4) antibody
  • kallikrein-related peptidase 4 (Klk4) antibody
  • AI2A1 antibody
  • ARM1 antibody
  • EMSP antibody
  • Emsp1 antibody
  • ESMP1 antibody
  • kallikrein antibody
  • KLK-L1 antibody
  • PRSS17 antibody
  • PSTS antibody

Protein level used designations for KLK4

kallikrein 4 (prostase, enamel matrix, prostate) , kallikrein-4 , protease, serine 17 (enamel matrix, prostate) , androgen-regulated message 1 , enamel matrix serine protease 1 , enamel matrix serine proteinase 1 , kallikrein-like protein 1 , prostase , serine protease 17 , Enamel matrix serine proteinase 1

56640 Mus musculus
9622 Homo sapiens
408210 Rattus norvegicus
Selected quality suppliers for anti-Kallikrein 4 (KLK4) Antibodies
Did you look for something else?